Development & Funding
From Innovation to Patient Impact
We are currently pursuing non-dilutive funding to advance our dental bone graft material through preclinical testing and toward 510(k) clearance.
Interested in supporting our work?
We welcome conversations with funders, partners, and collaborators.
Our Path to 510(k)
Four steps to the dental market.
Preclinical Studies
In vitro and in vivo evaluation of safety and performance.
Grant Funding
● Current stageNon-dilutive funding to complete testing and regulatory studies.
510(k) Submission
Target submission following completion of preclinical studies.
Dental Market Entry
Synthetic bone graft for dental applications.
Grant Applications
Ascender Grant
University of Utah
STTR Phase I/II Fast-Track
National Institutes of Health (NIH)
Downstream Opportunities
Our material platform also enables custom-engineered scaffolds for larger orthopedic applications, including critical-size defects and complex bone reconstruction.